Popular Articles
Benefits Of Grapefruit

Interest Groups Crowd Airwaves, Pursue Lawmakers
"The increasingly heated fight over health-care legislation is saturating the summer airwaves, with groups on all sides of the debate pouring tens of millions of dollars into advertising campaigns designed to push the cause of reform forward, slow it down or stop it in its tracks," the Washington Post reports. So far, drug makers, labor groups, Democrats and Republicans - among others - have spent $52 million to finance the ad campaigns, a heady start that could lead to a "record-breaking legislative battle."
generic viagra online
World Economic Forum On Africa Begins; Reports Examine African Development
New Era examines discussions at the meeting over how "an acute scarcity of financial res is threatening to set back the commendable strides achieved in the global fight against HIV/AIDS pandemic within the next three to five years." The Global Fund To Fight AIDS, Tuberculosis and Malaria"s Director for the Africa Unit Fareed Abdullah said during a news briefing at the conference, "There is no[t] enough money on the table for antiretroviral (ARV) treatments. It is a massive conundrum. The funding gap would start to hit in the period going forward."
News of the day
"What Must EPS Pilot Prove?" Asks NPA
The NPA is asking its members to utilise the new NPA IT forums website to comment on the criteria that should be used to demonstrate that EPS is operationally functional ahead of national roll-out. The NPA believes that EPS must work technically, be business and operationally functional, improve service delivery at pharmacies, and is safe for patients, before full roll-out can be contemplated. The website, http://itforums.npa.co.uk, provides an opportunity for members throughout the UK to voice their opinions on the IT programmes affecting their country or on general IT topics which affect all nations.
Cardiovascular

FDA Warns Consumers Not To Use Body Building Products Marketed As Containing Steroids Or Steroid-Like Substances

The U.S. Food and Drug Administration issued a Public Health Advisory (PHA) warning consumers to stop using body building products that are represented as containing steroids or steroid-like substances. Many of these products are marketed as dietary supplements. The agency also issued a Warning Letter to American Cellular Laboratories Inc. for marketing and distributing body building products containing synthetic steroid substances. Although these products are marketed as dietary supplements, they are not dietary supplements, but instead are unapproved and misbranded drugs. The PHA notifies consumers and health care professionals that the FDA has received reports of serious adverse events associated with the use of body building products that claim to contain steroids or steroid-like substances. Those adverse events include cases of serious liver injury, stroke, kidney failure and pulmonary embolism (artery blockage in the lung). The PHA also advises consumers to stop taking body building products from any manufacturer that claim to contain steroid-like substances or to enhance or diminish androgen-, estrogen-, or progestin-like effects in the body. The FDA has received five adverse event reports, including serious liver injury, in men taking products marketed as dietary supplements by American Cellular Laboratories including TREN-Xtreme and MASS Xtreme. Acute liver injury is generally known to be a possible side effect of using products that contain anabolic steroids. Some of the cases resulted in hospitalization, but there were no reports of death or acute liver failure. "Products marketed for body building and claiming to contain steroids or steroid-like substances are illegal and potentially quite dangerous," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "The FDA is taking enforcement action today to protect the public." The products listed in the Warning Letter to American Cellular Laboratories Inc., include "TREN-Xtreme," "MASS Xtreme," "ESTRO Xtreme," "AH-89-Xtreme," "HMG Xtreme," "MMA-3 Xtreme," "VNS-9 Xtreme," and "TT-40-Xtreme," and are sold on the Internet and in some stores. These products, which claim to contain steroid-like ingredients but in fact contain synthetic steroid substances, are unapproved new drugs because they are not generally recognized as safe and effective. In addition, the products are misbranded because the label is misleading and does not provide adequate directions for use. Consumers taking body building supplements that claim to contain steroids or steroid-like substances should stop taking them immediately. Consumers should also consult a health care professional if they suspect they are experiencing problems associated with the products. Health care professionals and consumers are encouraged to report adverse events that may be related to the use of these types of products to the FDA"s MedWatch Program by phone at 1-800-FDA-1088 or by fax at 1-800-FDA-0178 or by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787. To view the Public Health Advisory: see here. To view the July 27, 2009 Warning Letter to American Cellular Laboratories Inc., and the FDA consumer article on body building products marketed as containing steroids or steroid-like substances: see here. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):